Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Thursday’s Market Recap (10/30/2008)
Oct 30, 2008 09:39 PM
- Earnings Review Of Some Market Movers: ABC, XOM, ICE, MYL, CI, MOT
Oct 30, 2008 09:51 AM
- Johnson and Johnson Shines, Raises Full-Year Guidance
Oct 14, 2008 05:58 PM
- In a Market Like This You want to Own Something Safe and Boring like a Generic Drug Stock
Oct 10, 2008 04:35 PM
- 5 Forward-Looking Trends In Healthcare
Oct 02, 2008 02:08 PM
- Analyst Comments: Hess Corp, Mylan, AvalonBay, Abbott Labs, Trimble, NCR Corp, Vertex Pharma, American Tower, Sony, Washington Federal, Boston Properties, Johnson & Johnson, Matsushita, Deckers, Mechel Steel, Kroger
Sep 18, 2008 01:37 PM
- Pros and Cons of Owning Mylan Inc
Sep 10, 2008 09:51 PM
- Checking In On Daniel Loeb's Third Point LLC
Aug 27, 2008 01:52 PM
- Analyst Comments: Westamerica, Shaw Comm, NVIDIA, Mylan Generics, Kohl, Cincinnati Bell, American Oil and Gas, NetEase.com, Integrated Device, Kodiak Oil, Centurytel
Aug 17, 2008 12:52 PM
- Bookkeeping: Initiating Millipore Position
Aug 15, 2008 02:46 PM
- Election to benefit some industries, harm others
Nov 02, 2008 09:57 AM
- The Pittsburgh Tribune-Review Ron DaParma Column: Washington County Tax Rates, Transportation Attractive
Sep 28, 2008 04:11 AM
- AIG, Circuit City, Morgan Stanley among big movers
Sep 17, 2008 08:04 PM
- AIG, Circuit City, Morgan Stanley among big movers
Sep 17, 2008 02:10 PM
- Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
Dec 02, 2008 07:30 AM
- Mylan Confirms First-to-File Patent Challenge Relating to AMRIX(R)
Dec 01, 2008 08:02 AM
- Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
Nov 18, 2008 08:01 AM
- Mylan Receives Tentative FDA Approval for the Generic Version of the Antidepressant Effexor XR(R)
Nov 17, 2008 08:04 AM
- Zacks PEG Ratio Strategy Highlights: Deckers Outdoor, Mylan, Interactive Brokers Group and Perfect World
Nov 11, 2008 04:15 PM
- Mylan's Dey L.P. Announces Establishment of 'J-Code' for Perforomist(TM) Inhalation Solution
Nov 06, 2008 08:45 AM
- Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately
Nov 04, 2008 12:49 PM
- Mylan Declares Quarterly Preferred Stock Dividend
Oct 30, 2008 12:09 PM
- Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
Oct 30, 2008 07:31 AM
- Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI
Oct 29, 2008 01:01 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
MYL
|
Compare to S&P
|
| YTD |
-33.43 %
|
-0.01 %
|
| 4 Weeks |
2.97 %
|
22.01 %
|
| 12 Weeks |
-15.68 %
|
21.65 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 43.75 %
|
|
EPS Growth in Last Year: -25.81 %
|
|
Sales Growth in Last Quarter: 37.71 %
|
|
Sales Growth in Last Quarter: 250.73 %
|
|
|
